Clinical Laserthermia Systems AB (publ) Working Capital to Net Assets Ratio
Clinical Laserthermia Systems AB (publ) working capital to net assets ratio. Clinical Laserthermia Systems AB (publ) (CLS-B) has a Working Capital to Net Assets ratio of -3.6% as of June 2026. Working capital of Skr-1.59 Million (current assets of Skr23.86 Million minus current liabilities of Skr25.45 Million) is measured against net assets of Skr44.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check CLS-B tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Clinical Laserthermia Systems AB (publ) (2008–2025)
Working capital to net assets ratio of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. This chart shows how Clinical Laserthermia Systems AB (publ)'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at -3.6%, reflecting working capital of Skr-1.59 Million against net assets of Skr44.50 Million SEK. See Clinical Laserthermia Systems AB (publ) defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Clinical Laserthermia Systems AB (publ) Working Capital to Net Assets Ratio by Year (2008–2025)
Clinical Laserthermia Systems AB (publ) working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CLS-B total asset value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.8% | Skr29.12 Million | Skr66.48 Million | Skr39.12 Million | Skr10.00 Million | ▲ +4.9 pp |
| 2024 | 38.9% | Skr25.54 Million | Skr65.69 Million | Skr38.41 Million | Skr12.87 Million | ▲ +8.6 pp |
| 2023 | 30.3% | Skr13.17 Million | Skr43.53 Million | Skr27.14 Million | Skr13.97 Million | ▲ +251.2 pp |
| 2022 | -220.9% | Skr-17.38 Million | Skr7.87 Million | Skr24.26 Million | Skr41.64 Million | ▼ -206.6 pp |
| 2021 | -14.3% | Skr-3.03 Million | Skr21.18 Million | Skr42.42 Million | Skr45.45 Million | ▲ +51.3 pp |
| 2020 | -65.6% | Skr-9.13 Million | Skr13.93 Million | Skr20.90 Million | Skr30.03 Million | ▲ +199.0 pp |
| 2019 | -264.6% | Skr-18.51 Million | Skr7.00 Million | Skr12.55 Million | Skr31.06 Million | ▼ -313.0 pp |
| 2018 | 48.4% | Skr24.09 Million | Skr49.81 Million | Skr31.30 Million | Skr7.21 Million | ▲ +18.5 pp |
| 2017 | 29.9% | Skr9.85 Million | Skr33.00 Million | Skr20.40 Million | Skr10.54 Million | ▲ +47.3 pp |
| 2016 | -17.5% | Skr-2.98 Million | Skr17.06 Million | Skr7.26 Million | Skr10.24 Million | ▼ -22.1 pp |
| 2015 | 4.6% | Skr901.59K | Skr19.46 Million | Skr3.71 Million | Skr2.81 Million | ▼ -42.4 pp |
| 2014 | 47.1% | Skr14.86 Million | Skr31.58 Million | Skr20.24 Million | Skr5.38 Million | ▲ +1.8 pp |
| 2013 | 45.3% | Skr11.81 Million | Skr26.09 Million | Skr14.84 Million | Skr3.04 Million | ▲ +15.2 pp |
| 2012 | 30.1% | Skr5.14 Million | Skr17.09 Million | Skr8.04 Million | Skr2.89 Million | ▲ +21.9 pp |
| 2011 | 8.2% | Skr890.04K | Skr10.83 Million | Skr2.92 Million | Skr2.03 Million | ▼ -13.0 pp |
| 2010 | 21.2% | Skr2.19 Million | Skr10.36 Million | Skr3.39 Million | Skr1.20 Million | ▲ +11.1 pp |
| 2009 | 10.1% | Skr667.09K | Skr6.63 Million | Skr1.65 Million | Skr983.65K | ▼ -22.1 pp |
| 2008 | 32.2% | Skr1.18 Million | Skr3.68 Million | Skr2.23 Million | Skr1.05 Million | — |